Introduction
Ankylosing spondylitis (AS) is a progressive chronic disease characterized by inflammatory response and pathological mineralization. The prevalence of AS is 0.24% in the Chinese population, which is similar to the incidence in Caucasians (1) . Twin and family studies have shown that genetic factors play an important role in the pathogenesis of AS. Most previously identified genetic risk variants for AS are related to the immune response. Until recently, in a GWAS study in the Chinese Han population, Gu et al. (2) discovered two new susceptibility loci rs4552569 and rs17095830 near genes (between HAPLN1-EDIL3 at 5q14.3 and within ANO6 at 12q12) related to cartilage development and bone formation. Our previous study also identified a novel single nucleotide polymorphism (SNP) site (c.4488+74 G > A) in low-density lipoprotein receptor-related protein 5 (LRP5) gene was associated with AS in the Chinese Han population (3) . These data support the hypothesis that specific polymorphisms in the bone formation genes, in particular pathological mineralization-related genes might predispose to AS.
Multiple lines of evidence indicated the potential importance of extracellular pyrophosphatase metabolism regulators tissue-nonspecific alkaline phosphatase (TNAP) and the human orthologue of mouse progressive ankylosis (ANKH) in the pathological mineralization of AS (4) . Furthermore, several human and mouse diseases manifested by hydroxyapatite (HA) crystal deposition in the soft tissues of tendons and/or ligaments resembling
Summary
The aim of this study was to investigate two mineralization-related genes TNAP and ANKH polymorphisms associated with ankylosing spondylitis (AS) in the North Chinese Han population. We carried out a case-control study in Chinese AS cohorts involving 278 AS patients and 286 unrelated healthy controls. Five TNAP SNPs (rs3200254, rs1256348, rs1472563, rs1780329, rs3767155) and four ANKH SNPs (rs25957, rs26307, rs27356, rs28006) were genotyped by the Multiplex Snapshot method. There were significant differences in genotype (permutated p = 0. 
Patients and Materials

Patients
We analyzed nine SNPs in 278 unrelated Chinese Han AS patients (215 male and 63 female) and 286 healthy Chinese Han controls (206 male and 80 female) in Shandong Province, in North China. All of the case and control subjects were original local residents of Shandong Province of China. Patients with AS was diagnosed according to the modified New York criteria and were patients in Shandong Provincial Hospital and LinYi People's Hospital. The healthy control subjects were matched to the patients in sex, age and geographic location. The study was approved by the ethics committee of our institution, and written informed consent was obtained.
Genotyping
Nine previously reported polymorphisms of TNAP (rs3200254, rs1256348, rs1472563, rs1780329, rs3767155) and ANKH (rs25957, rs26307, rs27356, rs28006) were genotyped by the Multiplex Snapshot technique according to the manufacturer's protocol. Briefly, all nine SNPs were amplified by a Multiplex PCR kit (Qiagen, Germany). The PCR products were included in a single base extension (SBE) reaction with a SNaPshot Multiplex reagent Kit (Applied Biosystems). Snapshot products were then analyzed in the ABI PRISM 3130xl Genetic Analyzer (Applied Biosystems). Genotypes were determined by GeneMapper 4.1 software (Applied Biosystems). Genotyping was tested repetitively in 10% masked random samples by different investigators and all the results were completely concordant. Detailed information on the PCR primers and SBE oligonucleotides used are shown in supplemental Table S1 (http://www.biosciencetrends. com/docindex.php?year=2013&kanno=2).
Statistical analysis
Hardy-Weinberg equilibrium was tested for each SNP on controls. Genotype and allele distributions between cases and controls were compared using χ 2 tests. The main analysis used to test for association was multiple logistic regression models, adjusted for age and gender. Multiple testing corrections were performed based upon 10,000 random permutations of the sample data. All above analyses were run using PLINK v1.07. Haplotype analyses were performed using the Haploview 4.2 program. Statistical power was estimated using STPLAN 4.3 software. The level of significance for all statistical tests was defined as a p value < 0.05.
Results
The alleles and genotypes frequencies of AS patients and controls in the total samples are given in Table  1 . The distribution of genotypes of TNAP and ANKH polymorphisms were within the range of HardyWeinberg equilibrium. We estimated the power of our study material and found that our sample size had more than 80% power to detect an odds ratio (OR) of 1.50 for AS between carriers and non carriers with a significance level (alpha) of 0.05 for each SNP.
SNPs rs1256348 of TNAP, rs26307 and rs27356 of ANKH showed a significant association with AS (rs1256348 genotype p = 0.0499, allele p = 0.016; rs26307 genotype p = 0.0101, allele p = 0.00195; rs27356 genotype p = 0.0119, allele p = 0.0085, respectively), but only rs26307 remains significant after multiple testing using 10,000 permutations (genotype permutated p = 0.00481, allele permutated p = 0.0126), and rs27356 showed a marginal statistically significant level (genotype permutated p = 0.055, allele permutated p = 0.0596). The T allele of rs26307 significantly lowered the risk of developing AS (OR = 0.634, 95% CI = 0.475-0.847).
In order to rule out confounding in our crude association analyses, we reevaluated the polymorphism effect of rs26307 and rs27356 under 3 different models using logistic regression adjusted for age and gender. The ANKH rs26307 polymorphism was found to decrease the risk of AS using the additive model (CC The linkage disequilibrium (LD) block structure revealed one haplotype block including rs26307 and rs27356 in the ANKH gene (Figure 1) . The major haplotype combination of rs26307 (C) and rs27356 (T) is significantly associated with AS as a predisposing common haplotype (OR = 1.53, 95%CI = 1.165-2.071, p = 0.0026, permutation 10,000 corrected p = 0.0103); the minor haplotype combination of rs26307 (T) and rs27356 (C) defined a significantly protective common that a TNAP haplotype marker [rs3767155(G)/ rs3200254(G)/rs1780329(T)] in men is significantly associated with AS in multiplex families affected (8) . Our results revealed no association between AS and these three TNAP variants, either individually or by conforming haplotypes, which contradicts the results of Tsui HW et al., and is consistent with the results of Zhang et al. in a South Chinese population (9) . We further revealed that no association exists between AS and the other two TNAP variants rs1256348 and rs1472563 in the Northern Chinese population, which is not consistent with the results of Tsui HW et al. (8) . In agreement with the results of the previous study in the Chinese population (9), our data do not support the speculation that the TNAP gene confers susceptibility to AS in the Chinese Han population.
Four variants in ANKH (rs27356, rs26307, rs25957, and rs28006) have previously been genotyped in AS patients in two independent studies in Caucasian populations, but their results were inconsistent. In a study in a Portuguese population, the four markers demonstrated no significant single-locus disease associations with AS and disease severity, as measured by BASDAI, BASFI, BASMI, or mSASSS. However, in another study in a Canadian population, ANKH rs26307 was significantly associated with AS only in affected men; furthermore, a haplotype marker [rs26307/ rs27356] at the 3' end of the gene was significantly associated with AS in men while another haplotype haplotype (OR = 0.659, 95%CI = 0.487-0.890, p = 0.0064, permutation 10,000 corrected p = 0.0264) ( Table 2 ).
Discussion
In order to better understand the role of TNAP and ANKH in the pathological mineralization of AS, we conducted an analysis testing the association of their polymorphism genes to AS patients in a Northern Han Chinese population.
A previous family-based association study by Tsui HW et al. in the Canadian population documented marker [rs28006/rs25957] at 5' end of the gene was significantly associated with AS in women (6) . In the present study, we found a positive association between ANKH rs26307 polymorphism and AS. There was a significant difference in genotype distribution of rs26307 between AS and controls even after adjusting for age and gender. The presence of the minor T allele has a protective role for developing AS when compared with the presence of the major C allele, which can also be interpreted as a risk factor. Also, our results reflected a relationship between the ANKH haplotype (rs26307/ rs27356) and the risk of AS, suggesting that the minor alleles [rs26307(T)/rs27356(C)] were a protective factor for AS. However, no association between the haplotype [rs26307(C)/rs27356(C)] and AS were observed in this study. Furthermore, no significant interaction between gender and rs26307 genotype and halpotype has been identified in this study, which is different from the results of Tsui et al. (6) .
In conclusion, our findings suggest that genetic variant rs26307 at ANKH might influence susceptibility to AS in a Northern Han Chinese population but without a strong gender predilection. Further genetic association studies with a larger sample and functional analysis are needed to investigate the potential roles of ANKH in the mineralization pathogenesis of AS.
